EGFR and cervical carcinoma: EGFR activation induces translocation of PKM2 into the nucleus, where PKM2 acts both as a protein kinase and a transcriptional coactivator for hypoxia-inducible factor alpha (HIF-1α) in HeLa cervical carcinoma cells (21, 38).